These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11729239)

  • 21. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.
    Ruschitzka F; Shaw S; Gygi D; Noll G; Barton M; Lüscher TF
    J Am Soc Nephrol; 1999 May; 10(5):953-62. PubMed ID: 10232680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats.
    Lavoie P; Robitaille G; Agharazii M; Ledbetter S; Lebel M; Larivière R
    J Hypertens; 2005 Oct; 23(10):1895-903. PubMed ID: 16148614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat.
    Ficai S; Herizi A; Mimran A; Jover B
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1100-3. PubMed ID: 11903325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
    Seccia TM; Caroccia B; Gioco F; Piazza M; Buccella V; Guidolin D; Guerzoni E; Montini B; Petrelli L; Pagnin E; Ravarotto V; Belloni AS; Calò LA; Rossi GP
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27444511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.
    Pollock DM; Derebail VK; Yamamoto T; Pollock JS
    Gen Pharmacol; 2000 May; 34(5):337-42. PubMed ID: 11368889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice.
    Flamant M; Tharaux PL; Placier S; Henrion D; Coffman T; Chatziantoniou C; Dussaule JC
    FASEB J; 2003 Feb; 17(2):327-9. PubMed ID: 12475899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2002 Oct; 13(10):2464-77. PubMed ID: 12239235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.
    Suen RS; Rampersad SN; Stewart DJ; Courtman DW
    Am J Pathol; 2011 Sep; 179(3):1549-59. PubMed ID: 21718678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
    Tharaux PL; Chatziantoniou C; Casellas D; Fouassier L; Ardaillou R; Dussaule JC
    Circulation; 1999 Apr; 99(16):2185-91. PubMed ID: 10217661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts.
    An SJ; Boyd R; Zhu M; Chapman A; Pimentel DR; Wang HD
    Cardiovasc Res; 2007 Sep; 75(4):702-9. PubMed ID: 17391658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
    Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin ET(B) receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet.
    Kittikulsuth W; Looney SW; Pollock DM
    Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):362-70. PubMed ID: 23713708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro.
    van Det NF; Tamsma JT; van den Born J; Verhagen NA; van den Heuvel LP; Löwik CW; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
    J Am Soc Nephrol; 1996 Jul; 7(7):1015-23. PubMed ID: 8829116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1.
    Suzuki Y; Lopez-Franco O; Gomez-Garre D; Tejera N; Gomez-Guerrero C; Sugaya T; Bernal R; Blanco J; Ortega L; Egido J
    Am J Pathol; 2001 Nov; 159(5):1895-904. PubMed ID: 11696450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
    FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.